Home › Funds › Novo Holdings A/S › SRRK

Novo Holdings A/S position in SRRK

SCHOLAR ROCK HLDG CORP · Health Care

Novo Holdings A/S reported holding 460,002 shares of SRRK (SCHOLAR ROCK HLDG CORP) in its Q3 2026 13F filing — a position valued at US$22.2M, representing 1.49% of its reported portfolio and ranking #19 among its reported holdings. Novo Holdings A/S first reported this position in Q3 2026.

Latest position (Q3 2026)460.00K sh
Reported value held$22.23M
Portfolio Weight1.49%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Novo Holdings A/S's SRRK position evolved

Novo Holdings A/S first disclosed a stake in SRRK in Q3 2026 at 460,002 shares (US$22.2M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 460.00K $22.23M New

About SRRK and 13F data

SRRK (SCHOLAR ROCK HLDG CORP) is a Health Care company. 47 other funds we track also report a position in SRRK — the largest reported positions include Siren, L.L.C. (US$453.0M), Samsara BioCapital, LLC (US$333.3M), Orbis Allan Gray Ltd (US$293.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SRRK

All SRRK fund holders →

FAQ

How long has Novo Holdings A/S held SRRK?

Novo Holdings A/S has disclosed SRRK holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Novo Holdings A/S's current position in SRRK?

As of Q3 2026, Novo Holdings A/S holds 460.00K shares of SRRK (SCHOLAR ROCK HLDG CORP), valued at $22.23M, representing 1.49% of its reported portfolio and ranking #19.

Has Novo Holdings A/S been buying or selling SRRK?

In the latest 13F filing (Q3 2026), Novo Holdings A/S newly opened its position in SRRK.

Which other funds hold SRRK?

Other major institutional holders of SRRK include Siren, L.L.C., Samsara BioCapital, LLC, Orbis Allan Gray Ltd, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.